NCT00567047View on ClinicalTrials.gov

Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment

PHASE1CompletedINTERVENTIONAL

Enrollment

96

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2009

Conditions

Type-2 Diabetes

Interventions

DRUG

vildagliptin

Trial Locations (6)

23298

Novartis Investigator Site, Richmond

32809

Novartis Investigator Site, Orlando

33136

Novartis Investigator Site, Miami

37920

Novartis Investigator Site, Knoxville

55404

Novartis Investigator Site, Minneapolis

Unknown

Novartis Investigator Site, Kiel

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY